查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球经桡动脉入路设备市场 - 2023-2030 年
市场调查报告书
商品编码
1316239

全球经桡动脉入路设备市场 - 2023-2030 年

Global Transradial Access Device Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概述

2022 年，全球经桡动脉入路设备市场规模达到 20 亿美元，预计到 2030 年将达到 34 亿美元，2023-2030 年的复合年增长率为 7.4%。

经桡动脉技术是进行冠状动脉和外周血管造影和介入治疗的一种实用微创方法。经桡动脉导管术通常是一种更安全、更具成本效益、对患者更友好的手术。

市场动态

老年人口增长将推动市场增长

推动经桡动脉入路装置市场发展的主要因素之一是老年人口的不断扩大。相当一部分老年人患有心脏中风并接受心血管手术。在这些疾病中，充血性心力衰竭、冠状动脉疾病、高血压和心房颤动最为严重。

例如，根据美国心脏病协会期刊的估计，在 60 岁及以上的老年人中，55% 至 98% 至少患有两种慢性疾病。因此，老年人口的增加推动了市场的增长。

心血管疾病发病率上升推动市场增长

外周血管疾病等慢性疾病发病率的增加将推动市场增长。心血管疾病是常发疾病。中风、外周动脉疾病和主动脉疾病事件经常发生。例如，根据《纽约政府报告》，每年约有 80.5 万美国人心脏病发作。因此，心血管疾病发病率的增加将扩大市场增长。

设备的副作用将阻碍市场增长

经桡动脉入路设备的副作用会导致市场增长下降。使用经桡动脉入路器械会产生许多副作用。副作用包括

血管并发症。例如，经桡动脉入路后最常见的并发症是大约 5%的桡动脉闭塞风险。

如果艾伦测试符合标准，这种并发症在临床上并不严重。掌弓不完整和艾伦测试异常的患者在桡动脉闭塞后可能会出现手部缺血症状。因此，相关副作用会阻碍市场增长。

COVID-19 影响分析

COVID-19 大流行对经桡动脉入路装置市场产生了重大影响，给许多国家带来了前所未有的挑战。与心血管疾病相关的治疗程序延迟和手术推迟对经桡动脉入路装置的使用造成了影响。这导致经桡动脉装置市场的增长大幅下降。

目 录

第 1 章：研究方法与范围

  • 研究方法
  • 报告的研究目标和范围

第2章：定义和概述

第3章：执行摘要

  • 按产品类型分類的片段
  • 按应用分類的片段
  • 按最终用户分类
  • 按地区划分

第四章：动态

  • 影响因素
    • 驱动因素
      • 冠状动脉手术数量增加
      • 世界各地人们的意识不断提高
    • 限制因素
      • 与设备有关的并发症
    • 机会
      • 持续的研发和培训活动
    • 影响分析

第 5 章：行业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 监管分析

第 6 章：COVID-19 分析

  • COVID-19 分析
    • COVID-19 之前的情况
    • COVID-19 期间的情景
    • COVID-19 后的情况
  • COVID-19 期间的定价动态
  • 供求关系
  • 大流行期间与市场相关的政府倡议
  • 制造商的战略倡议
  • 结论

第 7 章 ：俄罗斯-乌克兰影响分析

第8章：按产品类型划分

  • 导管
  • 导丝
  • 鞘
  • 其他

第九章：按应用分类

  • 药物管理
  • 输血
  • 诊断
  • 其他

第10章：按最终用户

  • 医院
  • 专科诊所
  • 非住院手术中心
  • 其他

第 11 章：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 意大利
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 亚太其他地区
  • 中东和非洲

第 12 章 ：竞争格局

  • 竞争格局
  • 市场定位/份额分析
  • 合併与收购分析

第 13 章 ：公司简介

  • Ameco Medical
    • 公司概况
    • 产品组合和说明
    • 财务概况
    • 主要发展
  • BD
  • Angiodynamics, Inc.
  • Boston Scientific Corporation
  • Edward Lifesciences Corporation
  • Teleflex Incorporated
  • Merit Medical Systems
  • Medtronic
  • Nipro Medical Corporation
  • Oscor Inc.

第 14 章：附录

简介目录
Product Code: MD6507

Market Overview

Global Transradial Access Device Market reached US$ 2.0 billion in 2022 and is expected to reach US$ 3.4 billion by 2030 growing with a CAGR of 7.4% during the forecast period 2023-2030.

The transradial technique is a practical, minimally invasive approach to performing coronary and peripheral angiograms and interventions. Transradial catheterization is typically a safer, more cost-effective, and patient-friendly procedure.

Market Dynamics

Growing Geriatric Population will Drive the Growth of the Market

One of the primary driving factors that would boost the tranradial access device market is the expanding older population. A considerable proportion of the elderly population suffers from heart strokes and undergoes cardiovascular surgeries. Among these diseases, congestive heart failure, coronary artery diseases, hypertension, and atrial fibrillation have the greatest significance.

For instance, according to AHA Journals, it has been estimated that between 55% and 98% of older adults aged 60 years and over have at least 2 chronic diseases. Thus, increase in the population of older people is driving the market growth.

Increase in the Incidence of Cardiovascular Diseases is Driving the Market Growth

Increased disease incidences of chronic diseases, such as peripheral vascular diseases, will fuel market growth. Cardiovascular diseases are frequently occurring diseases. Stroke, peripheral arterial disease, and aortic disease events frequently occur. For instance, according to New York Govt., every year, about 805,000 Americans have a heart attack. Thus increase in the incidence of cardiovascular diseases will expand the market growth.

Side Effects Associated with the Devices Will Hamper the Market Growth

The side effects associated with transradial access devices can cause a decline in market growth. There are a number of side effects that are resulted due to the use of transradial access devices. The

use of transradial devices can lead to vascular complications. For instance, the most frequent complication after transradial access is about a 5% risk of radial artery occlusion.

This is a clinically insignificant complication if the Allen test is standard. Patients with incomplete palmar arch and abnormal Allen test may have symptoms of hand ischemia after radial artery occlusion. Thus, the side effects associated can hamper the market growth.

COVID-19 Impact Analysis

The COVID-19 pandemic epidemic has had a significant influence on the transradial access device market, posing unprecedented challenges to many countries. Delay in the treatment procedure and postponement of surgeries related to cardiovascular diseases has shown the impact on using the transradial access device. This resulted in a significant decline in the transradial device market growth.

Segment Analysis

The transradial access device market is segmented based on product type, application, and end user.

The Guidewires Segment Accounts for 27.3% the of Transradial Access Device Market Share

Guidewires are used during minimally invasive interventional procedures to traverse in the vascular system and access the desired position. Computer models are increasingly being used to predict the behavior of these instruments. Ace Angiography Guide Wires are hydrophilic guidewires and are used for percutaneous vessel entry to facilitate the subsequent introduction of an intravascular device. This device is supplied sterile in a peel-open pouch.

The purpose of a guidewire is to gain access to the blood vessels using a minimally invasive technique. For instance, according to CDC, coronary heart disease is the most common type of heart disease, killing 375,476 people in 2021. Thus, an increase in the number of coronary heart diseases expands the market growth. Thus, the cardiovascular disease segment holds the leading position in the market share.

Geographical Analysis

Asia Pacific accounted for Approximately 23.4% of the Market Share Owing to the Increasing Geriatric Population.

During the forecast period, Asia-Pacific is expected to grow at the fastest rate because of the growing geriatric population in nations such as India and China, the region has become a hotspot for cardiovascular disorders, increasing demand for coronary therapies and fueling company expansion. As well as an increase in the number of cases of cardiovascular disease and technical advancement in this region.

For instance, according to NLM, India has one of the world's highest burdens of cardiovascular disease (CVD). The annual number of CVD fatalities in India is expected to climb from 2.26 million in 1990 to 4.77 million in 2020. Over the last several decades, estimates of the prevalence of coronary heart disease in India have ranged from 1.6% to 7.4% in rural populations and from 1% to 13.2% in urban populations. As a result, diseases are on the rise, which contributes to the region's growth.

Competitive Landscape

The major global players in the transradial access device market include: AmecoMedical; BD; Angiodynamics, Inc.; BostonScientific Corporation; Edward Lifesciences Corporation; Teleflex Incorporated; Merit Medical Systems; Medtronic; Nipro Medical Corporation; Oscor Inc. among others.

Why Purchase the Report?

  • To visualize the transradial access device market segmentation based on product type, application, end-user, and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of transradial access device market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The transradial access device market report would provide approximately 53 tables, 54 figures, and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Application
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rise in the number of coronary artery procedures
      • 4.1.1.2. Increasing awareness among people around the world
    • 4.1.2. Restraints
      • 4.1.2.1. Complications Associated with the Devices
    • 4.1.3. Opportunity
      • 4.1.3.1. Continued research and developments and training initiatives
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers' Strategic Initiatives
  • 6.6. Conclusion

7. Russia-Ukraine Impact Analysis

8. By Product Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.1.2. Market Attractiveness Index, By Product Type
  • 8.2. Catheters
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Guidewires
  • 8.4. Sheaths
  • 8.5. Others

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Drug Administration
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Blood Transfusion
  • 9.4. Diagnostics
  • 9.5. Others

10. By End User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.1.2. Market Attractiveness Index, By End User
  • 10.2. Hospitals
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Specialty clinics
  • 10.4. Ambulatory surgical centers
  • 10.5. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.6.1. U.S.
      • 11.2.6.2. Canada
      • 11.2.6.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.6.1. Germany
      • 11.3.6.2. U.K.
      • 11.3.6.3. France
      • 11.3.6.4. Spain
      • 11.3.6.5. Italy
      • 11.3.6.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.6.1. Brazil
      • 11.4.6.2. Argentina
      • 11.4.6.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.6.1. China
      • 11.5.6.2. India
      • 11.5.6.3. Japan
      • 11.5.6.4. Australia
      • 11.5.6.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. Ameco Medical
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. BD
  • 13.3. Angiodynamics, Inc.
  • 13.4. Boston Scientific Corporation
  • 13.5. Edward Lifesciences Corporation
  • 13.6. Teleflex Incorporated
  • 13.7. Merit Medical Systems
  • 13.8. Medtronic
  • 13.9. Nipro Medical Corporation
  • 13.10. Oscor Inc.

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us